Skip to Content

Tag: GLP-1


Arti Masturzo

Specialty Providers

CCS ‘on right track’ 

March 13, 2024Theresa Flaherty, Managing Editor

GLP-1 medications misconception: Nearly 60% of diabetes patients surveyed by CCS mistakenly believe that GLP-1 medications alone are a silver bullet for managing their health. However, these drugs need to be integrated into a long-term holistic care plan.  Education and support gap: The survey results highlight a real need for better education and support for patients managing their diabetes. Diabetes suppliers are well-positioned to...

CCS, Coaching, Diabetes, Education, GLP-1


Read Full Articlered right arrow icon

Arti Masturzo

Specialty Providers

CCS survey: Education lacking for diabetes

March 7, 2024HME News Staff

DALLAS – CCS engaged independent market research firm PureSpectrum to survey more than 1,500 people living with diabetes to understand their attitude on an array of timely issues, including growing demand for GLP-1 weight loss drugs.  The survey found 57% of people with diabetes think GLP-1 weight loss drugs alone may be a silver bullet for helping achieve their health goals.  “GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health...

CCS, Diabetes, GLP-1


Read Full Articlered right arrow icon